Royal Bank Of Canada Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

Call Options

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2024 Nov 14, 2024	SELL	$90.87 - $102.43 $17 Million - $19.2 Million	-187,500 Reduced 61.56%	117,100 $11.6 Million
Q2 2024 Aug 14, 2024	BUY	$82.22 - $94.12 $10.3 Million - $11.8 Million	125,000 Added 69.6%	304,600 $28.2 Million
Q1 2024 Nov 05, 2024	SELL	$87.05 - $102.89 $10.9 Million - $12.9 Million	-125,000 Reduced 41.04%	179,600 $17 Million
Q1 2024 May 15, 2024	SELL	$87.05 - $102.89 $1.13 Million - $1.34 Million	-13,000 Reduced 6.75%	179,600 $17 Million
Q4 2023 Feb 14, 2024	BUY	$64.12 - $90.86 $294,952 - $417,956	4,600 Added 2.45%	192,600 $17.2 Million
Q3 2023 Nov 14, 2023	BUY	$71.88 - $85.76 $8.12 Million - $9.69 Million	113,000 Added 150.67%	188,000 $13.7 Million
Q2 2023 Aug 14, 2023	BUY	$75.38 - $90.23 $5.65 Million - $6.77 Million	75,000 New	75,000 $6.24 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

Goldman Sachs Group Inc New York, NY

12.7M
Shares

$1.21 Billion
0.21% of portfolio
Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.16 Billion
0.1% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$873 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$759 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$733 Million
0.45% of portfolio

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.